Status:

COMPLETED

Penetrance of Third Generation Fluoroquinolones in Eyes With Functioning Filtering Blebs

Lead Sponsor:

Indiana University School of Medicine

Conditions:

Cataract

Eligibility:

All Genders

Phase:

PHASE4

Brief Summary

Based on previous results with eyes without filtering blebs, the aqueous concentrations of ofloxacin and levofloxacin will exceed the concentration of ciprofloxacin after either topical or topical plu...

Detailed Description

The purpose of this study is to assay human aqueous for concentrations of ofloxacin, ciprofloxacin and levofloxacin after topical or combined topical and oral administration in eyes with filtering ble...

Eligibility Criteria

Inclusion

  • All patients with functioning filtering blebs will be evaluated prospectively for inclusion

Exclusion

  • Any subject who is already scheduled to have cataract surgery performed will qualify for participation with the exception of the following exclusion criteria:
  • Ongoing ocular inflammatory disease
  • Bleb leakage - determined by Seidel test
  • Suspected infection
  • Known contraindications to use of any of these study medications.
  • Pregnancy

Key Trial Info

Start Date :

November 1 2002

Trial Type :

INTERVENTIONAL

End Date :

May 1 2006

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT00392275

Start Date

November 1 2002

End Date

May 1 2006

Last Update

April 10 2013

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Indiana University Hospital

Indianapolis, Indiana, United States, 46202

2

Richard L Rodeboush VA Medical Center

Indianapolis, Indiana, United States, 46202

3

Wishard Memorial Hospital

Indianapolis, Indiana, United States, 46202